ESPION International, Inc. Accepted as Vendor With Direct Medical

ESPION International, Inc. (OTC: EPLJ), the maker of Artificial Intelligence based email gateway and network security products marks the recent agreement with Direct Medical as a vendor for distribution of products and services. Direct Medical is a resourcing partner for over 400 Hospitals and Medical facilities across the country. By becoming a vendor supplier to Direct Medical, ESPION now has direct access to market services to all of the existing and future members of this organization at preferred pricing and bypasses cumbersome bid processes. Direct Medical (http://www.dmcapital.com) specializes in providing group purchasing discounts to over 400 member companies and provides informative reviews and networking opportunities for its members. This agreement bolsters ESPION's current product offerings in the Health care and related fields where they currently provide email security and encryption products. "We feel that by entering into this relationship we further enhance our commitment and strengthen are ability to provide services in the Health care and related industries," states Randy Hymel, Director of Sales and Marketing at ESPION.

"ESPION has had significant success and has recently seen its sales jump following the August launch of our [MX] Lock product line. The MX Lock product provides advanced 1028-bit encryption dual key capabilities and employs its artificial intelligence engine to enable health care organizations to meet stringent Health Insurance Portability and Accountability Act (HIPAA) requirements as well as addressing critical data issues such as Personal Health Information (PHI)," commented Drew Burdsall, ESPION's Chairman and CEO.

ESPION International, Inc. a Costa Mesa, CA. based company is the foremost in development and deployment of Artificial Intelligence based solutions for email gateway and network security. The current ESPION product range offers appliances for email gateway security, anti-spam and secure email.

Investor Relations: Ryan Smith 714-436-0375